New EU Pharmaceutical Law and Policy

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

New EU Pharmaceutical Law and Policy

Similar Papers
  • Research Article
  • 10.21552/eplr/2021/4/9
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2021/3/10
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2020/4/10
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2018/3/11
EU Pharmaceutical Law and Policy
  • Jan 1, 2018
  • European Pharmaceutical Law Review

EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2018/2/11
New EU Pharmaceutical Law and Policy
  • Jan 1, 2018
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2017/1/11
New EU Pharmaceutical Law and Policy
  • Jan 1, 2017
  • European Pharmaceutical Law Review
  • Sabrina Röttger-Wirtz

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2019/2/10
New EU Pharmaceutical Law and Policy
  • Jan 1, 2019
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2021/1/9
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2019/1/12
New EU Pharmaceutical Law and Policy
  • Jan 1, 2019
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2019/3/10
New EU Pharmaceutical Law and Policy
  • Jan 1, 2019
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2018/1/12
New EU Pharmaceutical Law and Policy
  • Jan 1, 2018
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • Cite Count Icon 1
  • 10.21552/eplr/2018/4/11
EU Pharmaceutical Law and Policy
  • Jan 1, 2018
  • European Pharmaceutical Law Review

EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2020/1/12
New EU Pharmaceutical Law and Policy
  • Jan 1, 2020
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2020/2/13
New EU Pharmaceutical Law and Policy
  • Jan 1, 2020
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

  • Research Article
  • 10.21552/eplr/2020/3/9
New EU Pharmaceutical Law and Policy
  • Jan 1, 2020
  • European Pharmaceutical Law Review

New EU Pharmaceutical Law and Policy

More from: European Pharmaceutical Law Review
  • Research Article
  • 10.21552/eplr/2021/4/6
Portugal ∙ Resilience of Critical Infrastructures: The Portuguese Government Protection of Pharmaceutical and Medical Devices Industries Falls Short
  • Jan 1, 2021
  • European Pharmaceutical Law Review
  • M Ricardo

  • Open Access Icon
  • Research Article
  • 10.21552/eplr/2021/1/3
Editorial
  • Jan 1, 2021
  • European Pharmaceutical Law Review
  • S Röttger-Wirtz

  • Research Article
  • 10.21552/eplr/2020/4/8
The Italian Criminal Court of Rome: The Latest Chapter of the Avastin-Lucentis Saga
  • Jan 1, 2021
  • European Pharmaceutical Law Review
  • G Ragucci

  • Research Article
  • 10.21552/eplr/2021/2/9
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

  • Open Access Icon
  • Research Article
  • 10.21552/eplr/2021/4/3
Editorial
  • Jan 1, 2021
  • European Pharmaceutical Law Review
  • S Röttger-Wirtz

  • Research Article
  • 10.21552/eplr/2021/4/9
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

  • Research Article
  • Cite Count Icon 1
  • 10.21552/eplr/2021/4/4
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics
  • Jan 1, 2021
  • European Pharmaceutical Law Review
  • A Kiseleva + 1 more

  • Open Access Icon
  • Research Article
  • 10.21552/eplr/2020/4/3
Editorial
  • Jan 1, 2021
  • European Pharmaceutical Law Review

  • Research Article
  • 10.21552/eplr/2021/3/10
New EU Pharmaceutical Law and Policy
  • Jan 1, 2021
  • European Pharmaceutical Law Review

  • Research Article
  • 10.21552/eplr/2021/2/8
Jurisdiction
  • Jan 1, 2021
  • European Pharmaceutical Law Review

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon